Mehmet Hanifi Tanyeri̇

Mehmet Hanifi Tanyeri̇

Auto-generated profile, based on publicly available information

Mehmet Hanifi Tanyeri̇

Yenikent Government Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
MTMehmet H. Tanyeri
Mehmet H. Tanyeri
MBMehmet E. Buyukokuroglu
Mehmet E. Buyukokuroglu
PTPelin Tanyeri
Pelin Tanyeri
OMOguz Mutlu
Oguz Mutlu
AOAykut Ozturk
Aykut Ozturk
RKRumeysa K. Kaya
Rumeysa K. Kaya
Mirabegron is the first b3-adrenoceptor agonist to enter clinical practice and has been approved for the treatment of symptoms of OAB. The aim of this study is to investigate whether the mirabegron has an effect on depression, anxiety, learning, and memory. We investigated the effects of mirabegron on depression, anxiety, learning and memory by using forced swimming test, elevated plus maze test, passive avoidance and Morris water maze in mice. Imipramine and mirabegron (3, 6 and 9 mg/kg) significantly reduced immobility time in forced swimming test. Diazepam and mirabegron (3, 6 and 9 mg/kg) significantly increased the time spent in open arms and the number of entries to the open arms in elevated plus maze test. Furthermore, cognitive performance impaired with scopolamine has been significantly improved with 9 mg/kg mirabegron. Mirabegron (6 and 9 mg/kg) significantly increased the time spent in the target quadrant in naive mice. While scopolamine significantly increased the swimming speed, mirabegron (9 mg/kg) significantly decreased the swimming speed in scopolamine-treated mice. Mirabegron might be clinically useful for the treatment of OAB in elderly patients that should use drugs against depression and anxiety, without disrupt learning and memory.

1 December 2021 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
MTMehmet Hanifi Tanyeri̇
Mehmet Hanifi Tanyeri̇
MBMehmet Emin Büyükokuroğlu
Mehmet Emin Büyükokuroğlu
PTPelin Tanyeri̇
Pelin Tanyeri̇
RKRümeysa Keleş
Rümeysa Keleş
ŞBŞeyma Nur Başarir
Şeyma Nur Başarir
GUGüner Ulak
Güner Ulak
Objective: Ziprasidone, aripiprazole, blonanserin, cyamemazine, and nemonapride are atypical antipsychotic drugs used for the treatment of schizophrenia. This study aimed to identify the effects of these atypical antipsychotic drugs in mice isolated bladder using the organ bath systemMaterials and Methods: The mice were injected intraperitoneally with drugs for 21 days. The effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips. The detrusor strips were stimulated with KCl, then tissues were washed for a further 30 min and precontracted with a submaximal concentration of carbachol. After the contraction reached a plateau, cumulative concentration-response curves to isoproterenol were obtained.Results: We showed that carbachol-induced contractions dose-dependently relaxed by isoproterenol in mice detrusor strips obtained from ziprasidone, aripiprazole, blonanserin, and cyamemazine but not nemonapride treated group. However, none of the drug treatments had any effect KCl responses of mice's bladder.Conclusion: Ziprasidone, aripiprazole, blonanserin, and cyamemazine but not nemonapride increased the isoproterenol-induced relaxations of the detrusor smooth muscle indicates that it can increase the bladder capacity. We demonstrate that four drugs may represent a potential treatment for overactive bladder. They might be clinically useful for the treatment of overactive bladder in patients that should use antipsychotics.

21 February 2022 in Sakarya Medical Journal
Verified
Journal Article
Open access
MTMehmet Hanifi Tanyeri̇
Mehmet Hanifi Tanyeri̇
MBMehmet Emin Büyükokuroğlu
Mehmet Emin Büyükokuroğlu
PTPelin Tanyeri̇
Pelin Tanyeri̇
AÖAykut Öztürk
Aykut Öztürk
RKRümeysa Keleş
Rümeysa Keleş
OMOguz Mutlu
Oguz Mutlu
Objective: Overactive bladder (OAB) constitutes the majority of childhood incontinence causes. Oxybutynin is an antimuscarinic agent frequently used for children in the treatment of OAB. This study aimed to investigate the effects of an antimuscarinic drug oxybutynin on learning and memory. Materials and Methods: We assessed the effects of oxybutynin on learning and memory functions using the Passive Avoidance (PA) and the Morris Water Maze (MWM) Test in mice. Results: Oxybutynin treatment (1 mg/kg, 2 mg/kg, and 4 mg/kg) did not show a significant difference in the retention time on the second day compared to the control and oxybutynin (4 mg/kg) significantly prolonged the retention time in scopolamine-treated mice. In the MWM Test, oxybutynin (1 mg/kg, 2 mg/kg, and 4 mg/kg) has no effect on the time spent in the target quadrant. Scopolamine (0.6 mg/kg) alone significantly reduced time spent in the target quadrant, but oxybutynin (4 mg/kg) significantly prolonged time spent in the target quadrant in scopolamine-treated mice. Also, scopolamine significantly increased the mean distance to the escape platform, while oxybutynin (4 mg/kg) significantly decreased the mean distance to the escape platform in scopolamine-treated mice. Conclusion: In our study, oxybutynin did not affect learning and memory, but it plays a role ameliorating the learning and memory deficits. The results of this study show that the use of oxybutynin in patients with OAB does not affect learning and memory.

1 March 2022 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
MTMehmet Hanifi Tanyeri̇
Mehmet Hanifi Tanyeri̇
MBMehmet Emin Büyükokuroğlu
Mehmet Emin Büyükokuroğlu
PTPelin Tanyeri̇
Pelin Tanyeri̇
RKRümeysa Keleş
Rümeysa Keleş
ŞBŞeyma Nur Başarir Bozkurt
Şeyma Nur Başarir Bozkurt
GUGüner Ulak
Güner Ulak
Objective: Erectile dysfunction is a usual side effect of antipsychotic medications; this causes patients to avoid using drugs. The aim of this study to investigate the effects of iloperidone, paliperidone and loxapine on serotonin (5-HT), noradrenaline (NA), adenosine triphosphate (ATP) and potassium chloride (KCl)-induced contractions of the vas deferens in mice.Materials and Methods: The mice were randomly divided into experimental groups and treated by ip injection of drugs for 21 days. After the treatment, the effects of drugs were investigated on 5-HT, ATP, NA and KCl-induced contractile responses in the epididymal and prostatic portions of mice vas deferens strips. Results: 5-HT-induced contractile responses were significantly increased while ATP-induced contractile responses were significantly decreased in the both portions of the vas deferens obtained from the iloperidone, paliperidone and loxapine-treated groups. However, these drugs had no significant effect on NA- and KCl-induced contractions of mice vas deferens. Conclusion: These results showed that serotonin and ATP-induced contractions of vas deferens were affected by the chronic treatments of iloperidone, paliperidone, and loxapine. In mice chronically treated with these drugs, serotonergic and purinergic receptors may contribute to changes in vas deferens contractions that cause erectile dysfunction.

1 March 2022 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
MTMehmet Hanifi Tanyeri̇
Mehmet Hanifi Tanyeri̇
MBMehmet Emin Büyükokuroğlu
Mehmet Emin Büyükokuroğlu
PTPelin Tanyeri̇
Pelin Tanyeri̇
RKRümeysa Keleş
Rümeysa Keleş
ŞBŞeyma Nur Başarir Bozkurt
Şeyma Nur Başarir Bozkurt
GUGüner Ulak
Güner Ulak
Objective: The bladder normally shows no contractility or activity during the filling phase. In the overactive urinary bladder, spontaneous contractions and detrusor instability are seen in the filling phase and urinary incontinence occurs. This study aims to demonstrate the effects of first-generation antipsychotic haloperidol and second-generation antipsychotics olanzapine, risperidone, and clozapine on mice isolated bladder using the organ bath system. Materials and Methods: 63 male inbred mice were divided as saline, haloperidol 0.125 mg/kg, haloperidol 0.25 mg/kg, olanzapine 1 mg/kg, olanzapine 2 mg/kg, risperidone 0.25 mg/kg, risperidone 0.5 mg/kg, clozapine 1.25 mg/kg and clozapine 2.5 mg/kg groups. Mice were treated with drugs for 21 days. Then, the effects of drugs were investigated on isoproterenol-induced relaxation responses of carbachol-induced contractions in isolated detrusor strips. Results: We showed that carbachol-induced contractions relaxed by isoproterenol and papaverine in mice detrusor strips obtained from olanzapine, risperidone, and clozapine treated groups. There were no significant differences in KCl-induced contractile responses among the groups.Conclusion: Olanzapine, risperidone, and clozapine increased the isoproterenol-induced relaxations of the detrusor muscle that increased the bladder capacity. These drugs might be clinically useful for the treatment of overactive urinary bladder in patients that should use antipsychotic drugs.